Specific treatment of the neuroleptic malignant syndrome

Biological Psychiatry

Volumn 44, Issue 6, 1998, Pages 378-381

  Caroff, S N ^a   Mann, S C ^a   Keck P E , Jr ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BROMOCRIPTINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DANTROLENE; DOPAMINE RECEPTOR STIMULATING AGENT;

EDITORIAL; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MORTALITY; NEUROLEPTIC MALIGNANT SYNDROME; PARKINSON DISEASE; PRIORITY JOURNAL; REACTION TIME; RISK FACTOR; TREATMENT OUTCOME;

HUMANS; NEUROLEPTIC MALIGNANT SYNDROME;

EID: 0032530828     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00529-5     Document Type: Editorial

References (44)